[Form 4] Vivani Medical, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Vivani Medical, Inc. insider activity: A reporting person who is both a director and 10% owner of VANI disclosed two private purchases of Vivani Medical common stock dated 11/15/2025. One transaction involved buying 1,473,214 shares at $1.12 per share under a Share Purchase Agreement dated March 26, 2025, with gross proceeds of $1,649,999.68. A second transaction involved buying 264,550 shares at $1.26 per share under a Share Purchase Agreement dated August 11, 2025, with gross proceeds of $333,333.00. After these transactions, the reporting person is shown as beneficially owning 27,887,779 shares of Vivani common stock through a combination of direct holdings, family trusts, and related entities over which Gregg Williams has voting and dispositive power.

Insights

Equity Ownership and Governance Analyst

Large additional share purchases by a director/10% holder increase concentrated ownership and reinforce existing control structure.

The filing shows a major shareholder of Vivani Medical, Inc. purchased additional common shares in two private sale transactions. On 11/15/2025, the reporting person acquired 1,473,214 shares at $1.12 per share under a Share Purchase Agreement dated March 26, 2025, and 264,550 shares at $1.26 per share under a Share Purchase Agreement dated August 11, 2025. The gross amounts for these transactions are disclosed as $1,649,999.68 and $333,333.00, respectively, with prices matching the last reported Nasdaq sale prices on the prior trading days.

After these transactions, the reporting person is disclosed as beneficially owning 27,887,779 shares in total, held across several entities, with 4,799,200 shares owned directly and the balance through multiple trusts and LLCs. The filer is identified as both a Director and a 10% Owner, and has voting and dispositive power over all listed entities’ shares, which points to a highly concentrated voting position. This structure suggests that corporate decisions can be significantly influenced by this holder, and changes in their stake can be important to monitor.

The transactions were executed via private sale rather than on the open market, at prices tied to recent Nasdaq sale prices, and they expand the already significant beneficial ownership stake. The key items to watch going forward are any additional Form 4 filings that change this 27,887,779-share position, as well as any future updates to the Share Purchase Agreements referenced with dates March 26, 2025 and August 11, 2025, to understand how ownership concentration evolves over time.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/15/2025		P(1)		1,473,214	A	$1.12	22,824,029	I	See footnote(3)
Common Stock	11/15/2025		P(2)		264,550	A	$1.26	23,088,579	I	See footnote(3)
Common Stock								4,799,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person purchased 1,473,214 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of March 26, 2025 at a price of $1.12 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on March 25, 2025 (the day immediately prior to March 26, 2025). The gross proceeds from this private sale transaction were $1,649,999.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

2. The reporting person purchased 264,550 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,333.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

3. The reporting person owns 27,887,779 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 20,962,827 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

	/s/ Anthony Baldor, Attorney-in-fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vivani Medical (VANI) report on this Form 4?

The filing reports that a director and 10% owner of Vivani Medical, Inc. (VANI) executed two private purchases of Vivani common stock dated 11/15/2025, which are detailed in Table I and the footnotes.

How many Vivani Medical shares were purchased in the reported transactions?

The insider purchased 1,473,214 shares of Vivani common stock in one private sale and 264,550 shares in a second private sale, both reported as transactions dated 11/15/2025.

What prices were paid for the Vivani (VANI) insider share purchases?

For the first private sale, the insider paid $1.12 per share, which matched the last reported Nasdaq sale price on March 25, 2025. For the second private sale, the price was $1.26 per share, matching the last reported Nasdaq sale price on August 10, 2025.

What were the transaction sizes for the Vivani Medical insider purchases?

The gross proceeds for the first private sale transaction were $1,649,999.68, and the gross proceeds for the second private sale transaction were $333,333.00, as stated in the explanatory footnotes.

How many Vivani Medical (VANI) shares does the reporting person beneficially own after these transactions?

The reporting person is described as beneficially owning 27,887,779 shares of Vivani common stock in total, including shares held directly and shares held through various trusts and entities.

Who controls voting and dispositive power over the reported Vivani Medical shares?

The footnotes state that Gregg Williams has voting and dispositive power over all 27,887,779 shares held directly and through the listed trusts and entities.

What entities hold Vivani Medical shares for the reporting person?

The beneficial ownership includes shares held by the reporting person personally, the Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and the Sam B. Williams 1995 Generation-Skipping Trust.